Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy

Zhi DOU, Zongbin JIANG and Jincai ZHONG

Cancer pain is one of the most severe symptoms in patients with advanced cancer. Approximately 92% of patients with cancer pain have one or more pain symptoms caused directly by cancer, and about 21% of patients have one or more pain symptoms caused by cancer therapies.

The prevalence of neuropathic cancer pain (NCP) is estimated to be more than 30% in patients with cancer pain. Oral opioids are advocated in several international guidelines as first-line treatment for moderate-to-severe cancer pain. Although opioids can also be used to treat NCP, the response is often low, requiring higher doses.6,7 Furthermore, the quality of life (QOL) of patients with NCP refractory to opioid can be substantially reduced by its side effects, even when the dose is carefully titrated.

Pro Vida

Pro Vida

es un  programa  integral,  diseñado  para proveer  diversos  beneficios a pacientes  crónicos. Descuentos  desde su  primera compra, alianzas  con Laboratorios  y  Centro  de Diagnóstico y charlas educacionales al paciente crónico.

Si su médico le ha recetado alguna de las marcas que incluye el programa y  desea obtener todos los beneficios que Provida le ofrece, favor comunicarse al Call Center, para afiliarse y ser parte del programa.

Productos destacados

It seems we can't find what you're looking for.